medroxyprogesterone acetate injectable suspension

Generic: medroxyprogesterone acetate

Labeler: hikma pharmaceuticals usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name medroxyprogesterone acetate injectable suspension
Generic Name medroxyprogesterone acetate
Labeler hikma pharmaceuticals usa inc.
Dosage Form INJECTION, SUSPENSION
Routes
INTRAMUSCULAR
Active Ingredients

medroxyprogesterone acetate 150 mg/mL

Manufacturer
Hikma Pharmaceuticals USA Inc.

Identifiers & Regulatory

Product NDC 24201-150
Product ID 24201-150_3bf1d302-025e-447c-8480-065dd9f01849
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214309
Listing Expiration 2026-12-31
Marketing Start 2023-05-01

Pharmacologic Class

Classes
progesterone congeners [cs] progestin [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24201150
Hyphenated Format 24201-150

Supplemental Identifiers

RxCUI
1000126
UNII
C2QI4IOI2G

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name medroxyprogesterone acetate injectable suspension (source: ndc)
Generic Name medroxyprogesterone acetate (source: ndc)
Application Number ANDA214309 (source: ndc)
Routes
INTRAMUSCULAR
source: ndc

Resolved Composition

Strengths
  • 150 mg/mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (24201-150-01) / 1 mL in 1 VIAL (24201-150-00)
  • 25 VIAL in 1 CARTON (24201-150-25) / 1 mL in 1 VIAL (24201-150-00)
source: ndc

Packages (2)

Ingredients (1)

medroxyprogesterone acetate (150 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR"], "spl_id": "3bf1d302-025e-447c-8480-065dd9f01849", "openfda": {"unii": ["C2QI4IOI2G"], "rxcui": ["1000126"], "spl_set_id": ["0476eac5-d96c-4910-aa86-1ddeeefefe50"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (24201-150-01)  / 1 mL in 1 VIAL (24201-150-00)", "package_ndc": "24201-150-01", "marketing_start_date": "20230501"}, {"sample": false, "description": "25 VIAL in 1 CARTON (24201-150-25)  / 1 mL in 1 VIAL (24201-150-00)", "package_ndc": "24201-150-25", "marketing_start_date": "20230501"}], "brand_name": "Medroxyprogesterone Acetate Injectable Suspension", "product_id": "24201-150_3bf1d302-025e-447c-8480-065dd9f01849", "dosage_form": "INJECTION, SUSPENSION", "pharm_class": ["Progesterone Congeners [CS]", "Progestin [EPC]"], "product_ndc": "24201-150", "generic_name": "medroxyprogesterone acetate", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Medroxyprogesterone Acetate Injectable Suspension", "active_ingredients": [{"name": "MEDROXYPROGESTERONE ACETATE", "strength": "150 mg/mL"}], "application_number": "ANDA214309", "marketing_category": "ANDA", "marketing_start_date": "20230501", "listing_expiration_date": "20261231"}